Quentin M. Anstee (@qanstee) 's Twitter Profile
Quentin M. Anstee

@qanstee

Professor of Experimental Hepatology & Consultant Hepatologist: NAFLD/MASLD Treatment | Biomarkers | Pathogenesis | Genetics

ID: 2596299252

linkhttp://www.ncl.ac.uk/medical-sciences/people/profile/quentinanstee.html calendar_today30-06-2014 12:50:47

675 Tweet

1,1K Followers

361 Following

Jeffrey V. Lazarus (@jvlazarus) 's Twitter Profile Photo

I asked at #ALEH2024 if Latin America was ready to address this silent public health challenge? ...the MASLD/MASH #publichealth threat. And the answer, sadly is no - like the rest of the world journal-of-hepatology.eu/article/S0168-…

I asked at #ALEH2024 if Latin America was ready to address this silent public health challenge? ...the MASLD/MASH #publichealth threat. And the answer, sadly is no - like the rest of the world
journal-of-hepatology.eu/article/S0168-…
NHSA (@the_nhsa) 's Twitter Profile Photo

Great discussions about the excellence of health research coming out of the North of England, but also recognition of the ongoing challenges due to the inequity in research funding awarded to the North. Mayor Oliver Coppard @louiseckenny Hannah Davies Jo Rycroft-Malone

Great discussions about the excellence of health research coming out of the North of England, but also recognition of the ongoing challenges due to the inequity in research funding awarded to the North. <a href="/SouthYorksMayor/">Mayor Oliver Coppard</a> @louiseckenny <a href="/HannahDaviesHEN/">Hannah Davies</a> <a href="/jorycroftmalone/">Jo Rycroft-Malone</a>
Newcastle University (@uniofnewcastle) 's Twitter Profile Photo

🎉 We're celebrating rising 7 places to be placed 30th in The Times and The Sunday Times Good University Guide 2025. We've also had 11 subjects rank in their top 10 subject area rankings 🏆 #WeAreNCL

🎉 We're celebrating rising 7 places to be placed 30th in <a href="/thetimes/">The Times and The Sunday Times</a> Good University Guide 2025.

We've also had 11 subjects rank in their top 10 subject area rankings 🏆 

#WeAreNCL
Rohit Loomba (@drloomba) 's Twitter Profile Photo

Call for abstracts for the MetALD Conference in San Diego Nov 14 at Westin Gaslamp Quarter- A star-studded panel of faculty from over 25 institutions worldwide - Vincent Wong Marco Arrese, MD Quentin M. Anstee Daniel Huang Juan Pablo (JP) Arab, MD  Michael Charlton MD, FRCP metaldconference.org/agenda #livertwitter

Rohit Loomba (@drloomba) 's Twitter Profile Photo

Join leaders in the field from across the🌐& learn about opportunities & challenges in MetALD drug development/biomarkers in San Diego Westin Nov 14th! metaldconference.org Quentin M. Anstee UCSD Gastroenterology Vincent Wong AASLD #livertwitter EASLnews ACG Vijay Shah

Mazen Noureddin, MD, MHSc (@noureddinmd) 's Twitter Profile Photo

Breaking news. Sema hits both points for MASH resolution and Fibrosis improvement in the Ph 3 study! 62.9% vs 34.1% and 37% vs 22.5% respectively . Waiting to see F3, F2, titration and tolerance and drop out at #TLM24 #livertwitter Jörn Schattenberg Naim Alkhouri Rohit Loomba EASL Education

THRIVE Liver Cancer EU Project (@thrive_livercan) 's Twitter Profile Photo

🚨 THRIVE is at this year's #AASLD with some groundbreaking research presented by our partners! Curious about our involvement in the AASLD Foundation Annual Conference? Check out this quick thread 🧵👇 #LiverTwitter #AASLD2024

The Lancet Gastroenterology & Hepatology (@lancetgastrohep) 's Twitter Profile Photo

Quentin Anstee draws things to a close with data from a trial combining the DGAT2 inhibitor ervogastat and the acetyl coenzyme A carboxylase inhibitor clesacostat in patients with MASH and F2-3 fibrosis #TLM24 #LiverTwitter

Quentin Anstee draws things to a close with data from a trial combining the DGAT2 inhibitor ervogastat and the acetyl coenzyme A carboxylase inhibitor clesacostat in patients with MASH and F2-3 fibrosis #TLM24 #LiverTwitter
Newcastle Hospitals Research (@nuthresearch) 's Twitter Profile Photo

Delighted that we've been awarded funding for a Commercial Research Delivery Centre to give more people the opportunity to take part in research 👏 Find out more 👉bit.ly/4fgbiKj

Delighted that we've been awarded funding for a Commercial Research Delivery Centre to give more people the opportunity to take part in research 👏

Find out more 👉bit.ly/4fgbiKj
Newcastle University (@uniofnewcastle) 's Twitter Profile Photo

🎉Great news🎉 We've been ranked in the World Top 90 for Medical and Health and in the World Top 125 for Arts and Humanities, Life Sciences and Social Sciences in Times Higher Education World University Rankings by Subject 2025 🏆 #WeAreNCL #THEUniRankings #WUR2025

🎉Great news🎉

We've been ranked in the World Top 90 for Medical and Health and in the World Top 125 for Arts and Humanities, Life Sciences and Social Sciences in <a href="/timeshighered/">Times Higher Education</a> World University Rankings by Subject 2025 🏆

#WeAreNCL #THEUniRankings #WUR2025
Newcastle University (@uniofnewcastle) 's Twitter Profile Photo

🎉 Today we're celebrating as 12 of our subjects have been ranked within the world's top 100 in the latest QS World University Rankings by Subject. Congratulations to all our colleagues and teams involved in this fantastic achievement👏 #WeAreNCL #QS

🎉 Today we're celebrating as 12 of our subjects have been ranked within the world's top 100 in the latest QS World University Rankings by Subject.

Congratulations to all our colleagues and teams involved in this fantastic achievement👏

#WeAreNCL #QS
The Lancet Gastroenterology & Hepatology (@lancetgastrohep) 's Twitter Profile Photo

EMA recommends granting a conditional marketing authorisation in the EU for resmeritom for adults with non-cirrhotic MASH with moderate to advanced liver fibrosis, in conjunction with diet and exercise ema.europa.eu/en/news/first-… #LiverTwitter #MedTwitter